BiotechInnova

BiotechInnova is a reliable partner with over a decade of experience in healthcare and pharmaceuticals. The company is the result of 15 years of cutting-edge research and development by the founder and former CEO of NASDAQ biotech DS Healthcare Group (www.dslaboratories.com). DS Healthcare Group manufactured and developed sophisticated formulations that are prescribed and recommended by thousands of doctors and physicians. After the sale of DS Healthcare Group to an international pharmaceutical company, BiotechInnova was born to further advance innovation and performance of pharmaceutical agents and ingredients. The company has deep technical capabilities and regulatory expertise. Its client base includes a diverse selection of pharmaceutical companies, hospitals, academic, and government organizations from around the world. The latest round of investment, a $250.00K Seed Round, was secured on 02 December 2021 from Newchip Accelerator. With its headquarters in the United States, BiotechInnova stands as a promising player in the health care and pharmaceutical industries, poised to make significant strides in the advancement and performance of pharmaceutical agents and ingredients.